about
The expression and prognostic significance of retinoic acid metabolising enzymes in colorectal cancerAminoglutethimide-induced protein free radical formation on myeloperoxidase: a potential mechanism of agranulocytosisChemoprevention of Breast Cancer by Dietary PolyphenolsNovel Aromatase Inhibitors by Structure-Guided DesignThe Anti-Cancer Effect of Polyphenols against Breast Cancer and Cancer Stem Cells: Molecular MechanismsModelling inhibition of avian aromatase by azole pesticides.Estradiol is associated with mortality in critically ill trauma and surgical patients.Hybrid dual aromatase-steroid sulfatase inhibitors with exquisite picomolar inhibitory activity.Fathead minnow steroidogenesis: in silico analyses reveals tradeoffs between nominal target efficacy and robustness to cross-talk.Molecular characterization of aromatase inhibitor-resistant, tamoxifen-resistant and LTEDaro cell linesAnalgesic use and sex steroid hormone concentrations in postmenopausal women.(--)-Xanthatin selectively induces GADD45γ and stimulates caspase-independent cell death in human breast cancer MDA-MB-231 cells.GP88 (PC-Cell Derived Growth Factor, progranulin) stimulates proliferation and confers letrozole resistance to aromatase overexpressing breast cancer cellsDesign, synthesis, and biological evaluation of callophycin A and analogues as potential chemopreventive and anticancer agentsInvestigation of aromatase inhibitory activity of metal complexes of 8-hydroxyquinoline and uracil derivatives.Steroidal metabolites transformed by Marchantia polymorpha cultures block breast cancer estrogen biosynthesis.Dietary phenethyl isothiocyanate alters gene expression in human breast cancer cellsGrowth factor signaling enhances aromatase activity of breast cancer cells via post-transcriptional mechanisms.Mechanism of inhibition of estrogen biosynthesis by azole fungicides.3D QSAR studies, pharmacophore modeling and virtual screening on a series of steroidal aromatase inhibitors.Effects of modified Shu-Gan-Liang-Xue decoction combined with anastrozole on osteoblastic proliferation and differentiation of MC3T3-E1 cells.Evidence for an elevated aspartate pK(a) in the active site of human aromataseAromatase inhibitors and antiepileptic drugs: a computational systems biology analysis.Potential utility of natural products as regulators of breast cancer-associated aromatase promotersAromatase and dual aromatase-steroid sulfatase inhibitors from the letrozole and vorozole templates.Micro-RNA378 (miR-378) regulates ovarian estradiol production by targeting aromatase.The role of glucocorticoids in the immediate vs. delayed effects of acute ethanol exposure on cytokine production in a binge drinking model.The metabolic syndrome: A high-risk state for cancer?Cognitive changes associated with endocrine therapy for breast cancer.Coupled electron transfer and proton hopping in the final step of CYP19-catalyzed androgen aromatizationNative MAG-1 antibody almost destroys human breast cancer xenografts.Phosphorylation by p38 mitogen-activated protein kinase promotes estrogen receptor α turnover and functional activity via the SCF(Skp2) proteasomal complex.Variable phenotypes associated with aromatase (CYP19) insufficiency in humans.Aromatase inhibition by bioavailable methylated flavones.Chemical proteomic probes for profiling cytochrome p450 activities and drug interactions in vivo.Prediction of aromatase inhibitory activity using the efficient linear method (ELM)Fluorinated Sterols Are Suicide Inhibitors of Ergosterol Biosynthesis and Growth in Trypanosoma brucei.The what, why and how of aromatase inhibitors: hormonal agents for treatment and prevention of breast cancerPlasma estrone sulfate concentrations and genetic variation at the CYP19A1 locus in postmenopausal women with early breast cancer treated with letrozole.Structural and functional characterization of aromatase, estrogen receptor, and their genes in endocrine-responsive and -resistant breast cancer cells.
P2860
Q21090644-AF1E40C2-F6B4-4EF3-8F40-A143BA392BA1Q24680255-8750C3DC-B9A6-4EF5-9222-028F1301A1BDQ26773449-CBB96AAF-9909-47D6-90D6-320B1784B25AQ27672328-5E4AAF51-6B29-4962-9BCC-3A620F6D90C9Q28066752-CBED710D-DBF8-4420-9743-6C0446FDB2B9Q30386609-28750630-FAE1-41EA-AA3C-6AAC768EB938Q30440049-ACC95D23-760C-4686-B38F-43A35587796EQ33598615-06822ABE-81F9-4162-B784-0CDC4AC57D9AQ33616922-C9DAD7F5-1A6A-4C47-BE8B-5CE65B73D229Q33718304-96B2AB25-10A7-4C98-8C65-4452FDFF903CQ33780860-83CC8E39-F46A-4660-A6C2-9AB4EA0D2E9DQ33872756-3FFD2674-E4E1-4449-9AB3-7D0581409999Q33928138-669A63E0-9129-43B4-83CD-E958FBE9DE8CQ34042275-0D02D812-49F1-41B1-890A-CB6293573C21Q34074415-5C0346C3-D06E-471E-80E8-89E8ADBEA847Q34164697-279E1725-1124-4D32-B5C7-A152D4A57595Q34186892-324B48D9-788D-43C7-B041-8278F483C773Q34538422-C695478E-F674-4155-B4C1-9274A41C29F3Q34551659-11E5C850-6C6B-4A9A-92C3-36F06A5374EDQ34685559-AA1DC866-C6D6-42A9-A960-1329B911441EQ34731247-0D88A317-9E11-4618-A0CD-F6A077385CFEQ34958506-AEDCBFFB-AC6D-4314-A751-53AAC87242F5Q35086171-0ECA19C9-6735-4067-8D90-CD44916E24A8Q35124690-1F411ECF-3914-4695-9AE4-47D4EC6F4093Q35207866-00034FE7-190D-40AA-9E5F-A129F8234D1DQ35223019-A84DEAAA-2B09-4B21-AA88-2058B6DFEAAEQ35545573-2AA9377A-BE95-4CF4-A891-AECE4CD44A6AQ35607405-21807A47-06F7-4BBD-B39E-61CE89872FBAQ35660927-BCE89B98-F68A-4B3F-A949-EE5796A52171Q35889886-EBB4F60F-DA3F-4380-93E2-441E43B27CA0Q35906939-3BD4F2AC-0FDD-4917-B87E-B03C37F5011CQ35943932-0498C1EA-4A25-47D1-B66E-E40B1E005059Q35956583-7D6F2806-A3A6-4579-8161-FBA457DA1823Q36068274-CA62880D-3E3E-4AFF-81F6-E17B7D37F20AQ36097183-B9227D2E-D8ED-406C-BB30-420FA02EEA80Q36186719-602F1AAB-F672-4C41-BFE0-E07EDCFD0525Q36219533-1C791531-D66A-4B7C-95FD-72543E9A70C3Q36432163-25EB33B4-3F59-41DF-BFAA-43FE79EC0AD6Q36484937-35B85454-DE02-4C90-B79C-22BC5A580E36Q36578211-3153CF99-7DB5-4D08-AE49-736C82342E49
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Aromatase inhibitors in the treatment of breast cancer.
@ast
Aromatase inhibitors in the treatment of breast cancer.
@en
type
label
Aromatase inhibitors in the treatment of breast cancer.
@ast
Aromatase inhibitors in the treatment of breast cancer.
@en
prefLabel
Aromatase inhibitors in the treatment of breast cancer.
@ast
Aromatase inhibitors in the treatment of breast cancer.
@en
P356
P1433
P1476
Aromatase inhibitors in the treatment of breast cancer
@en
P2093
Edgar S Diaz-Cruz
Robert W Brueggemeier
P304
P356
10.1210/ER.2004-0015
P577
2005-04-06T00:00:00Z